|
|
|
|
Vol. 11, Issue 7, 2283-2295, July 2000
and
*Department of Biochemistry and Neuroscience Program, University of
Illinois, Urbana, Illinois 61801; and
The Vanderbilt
Cancer Center, Department of Cell Biology, School of Medicine,
Vanderbilt University, Nashville, Tennessee 37232
| |
ABSTRACT |
|---|
|
|
|---|
Previously, progesterone was found to regulate the initiation
and biosynthetic rate of myelin synthesis in Schwann cell/neuronal cocultures. The mRNA for cytochrome P450scc (converts cholesterol to
pregnenolone), 3
-hydroxysteroid dehydrogenase (3
-HSD, converts pregnenolone to progesterone), and the progesterone receptor were found
to be markedly induced during active myelin synthesis. However, the
cells in the cocultures responsible for these changes were not
identified. In this study, in situ hybridization was used to determine
the localization of the enzymes responsible for steroid biosynthesis.
The mRNA for cytochrome P450scc and 3
-HSD were detected only in
actively myelinating cocultures and were localized exclusively in the
Schwann cells. Using immunocytochemistry, with minimal staining of the
Schwann cells, we found the progesterone receptor in the dorsal root
ganglia (DRG) neurons. The progesterone receptor in the neurons
translocated into the nuclei of these cells when progesterone was added
to neuronal cultures or during myelin synthesis in the cocultures.
Additionally, a marked induction of the progesterone receptor was found
in neuronal cultures after the addition of progesterone. The induction
of various genes in the neurons was also investigated using mRNA
differential display PCR in an attempt to elucidate the mechanism of
steroid action on myelin synthesis. Two novel genes were induced in
neuronal cultures by progesterone. These genes, along with the
progesterone receptor, were also induced in cocultures during myelin
synthesis, and their induction was blocked by RU-486 (a progesterone
receptor antagonist). These genes were not induced in Schwann cells
cultured alone after the addition of progesterone. These results
suggest that progesterone is synthesized in Schwann cells and that it can indirectly regulate myelin formation by activating transcription via the classical steroid receptor in the DRG neurons.
| |
INTRODUCTION |
|---|
|
|
|---|
Myelin is a unique component of the nervous system
that allows for efficient saltatory conduction of action potentials
transmitted along axons. While many factors have been identified as
affecting the overall myelination process, the molecules responsible
for signaling and regulating specific steps in myelin synthesis remain to be determined. Recently, steroid biosynthesis and the influence of
various hormones on the central and peripheral nervous systems have
received widespread attention. Specifically, hormones such as thyroid
hormones and corticosteroids have been implicated in regulating the
differentiation of glial cells, suggesting a role for various hormones
in the myelination process (Walters and Morell, 1981
; Almazan et
al., 1985
; Koper et al., 1986
; Warringa et
al., 1987
; Kumar et al., 1989
; Tosic et al.,
1992
; Barres et al., 1994
). Estradiol and progesterone have
also been implicated in increasing the expression of myelin proteins
(Jung-Testas et al., 1994
; Robel and Baulieu, 1994
; Koenig
et al., 1995
; Jung-Testas et al., 1996b
; Notterpek et al., 1999
), while progesterone and
dexamethasone have been found to activate the promoters of peripheral
myelin protein-22 and P0 (Desarnaud et
al., 1998
; Melcangi et al., 1999
). The enzymes
responsible for progesterone biosynthesis, cytochrome P450scc and
3
-HSD, have been identified in the brain and spinal cord of the rat.
These enzymes also have been localized and identified in various cell
types [e.g., the neurons of the vestibular and hypoglossal nuclei,
cerebellar granule cells, Purkinje cells, primary glial cells, and
purified oligodendrocytes (Hu et al., 1987
; Jung-Testas
et al., 1989
; Robel and Baulieu, 1994
; Dupont et
al., 1994
; Sanne and Krueger, 1995
; Furukawa et al.,
1998
)].
Myelin synthesis can be induced in cocultures of Schwann cells
and DRG neurons. Recently, we demonstrated that progesterone added to
Schwann cell/neuronal cocultures decreased the time required for
initiation and increased the biosynthetic rate of myelin synthesis (Chan et al., 1998
). RU-486 (a progesterone receptor
antagonist) was found to inhibit myelin formation, demonstrating that
progesterone is an essential factor involved in myelin synthesis and
that its major mechanism of action is through the classical
progesterone receptor. The expression of the mRNA for cytochrome
P450scc, 3
-HSD, and the progesterone receptor were dramatically
induced in cocultures at the time of myelin synthesis. However, the
cells in these cocultures responsible for these changes were not identified.
During development or after nerve injury, complex interactions
between glial cells and neurons are responsible for the reciprocal regulation and dramatic modulation of gene expression in both types of
cells (for reviews see Doyle and Colman, 1993
; Reynolds and Woolf,
1993
). Previously, the expression of differentially regulated genes has
been investigated during peripheral nerve injury, and during the
differentiation of oligodendrocytes in the CNS (Stahl et
al., 1990
; Gillen et al., 1995
; Schaeren-Wiemers et al., 1995
). Similarly, axonal/Schwann cell contacts in
the peripheral nervous system are essential for the differentiation of
Schwann cells and for the morphogenesis of the axon (Salzer et
al., 1980
; Joe and Angelides, 1992
; De Waegh et al.,
1992
; Bolin and Shooter, 1993
; Einheber et al., 1993
;
Dugandzija-Novakovic et al., 1995
; Yin et al.,
1998
). The presence of inducible proteins responsible for steroid
biosynthesis and the dramatic effects of progestins and glucocorticoids
on myelin synthesis suggest that steroids and their metabolites may act
as signaling molecules between Schwann cells and neurons. Because
cytochrome P450scc, 3
-HSD, and steroid hormone receptors are
inducible proteins, they may be present or absent in cells under
various conditions. Consequently, to determine the mechanism of the
interactions that exist during myelin synthesis and to differentiate
between paracrine and/or autocrine signaling, it is important to
determine the localization of these enzymes and the corresponding
steroid receptors. Using oligonucleotide probes specific for cytochrome
P450scc and 3
-HSD, the localization and expression of the mRNA for
the enzymes were investigated by in situ hybridization.
Immunocytochemistry was employed for localization of the progesterone
receptor. In addition, mRNA differential display technology (Liang and
Pardee, 1992
; Liang et al., 1994
) was used on premyelinating
and myelinating cocultures, as well as on neuronal cultures, with and
without the addition of progesterone to identify changes in gene
expression (for a review utilizing differential display and
hormone-inducible gene expression, see Averboukh et al.,
1997
). The results suggest that progesterone is synthesized in Schwann
cells and that it is an essential signaling molecule that regulates
myelin synthesis through the classical steroid receptor in the DRG
neurons by activating transcription.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
DRG Neuron/Schwann Cell Cocultures
Purified neuronal and Schwann cell cultures were prepared using
modified methods according to Eldridge et al. (1987)
(Chan et al., 1998
). Briefly, neuronal cultures were established
from dorsal root ganglia neurons obtained from 15-d gestation Sprague Dawley rat embryos (Harlan, Indianapolis, IN). The dorsal root ganglia
neurons were dissociated with trypsin and plated onto collagen-coated
coverslips. Nonneuronal cells were eliminated by cycling with a medium
containing fluorodeoxyuridine. Neurons were then maintained 1 wk in a
medium consisting of 10% fetal bovine serum in Eagle's Minimal
Essential Medium (MEM) and 200 ng/ml nerve growth factor (M1 medium).
Schwann cells were isolated from the sciatic nerve of 4-day-old rat
pups (Brockes et al., 1979
). The sciatic nerves were
dissociated with trypsin and collagenase. The dissociated Schwann cells
were maintained for 3 to 5 days in a medium consisting of 10% fetal
bovine serum in DMEM (DMEM) with gentamicin and cytosine arabinoside to
eliminate fibroblasts. The purified Schwann cells were then used to
seed the purified neuronal cells and establish cocultures. The purified
neuronal cultures of ~ 70,000 cells were seeded with ~ 100,000 Schwann cells. Cocultures were then maintained in MEM with the
addition of 10% charcoal-filtered fetal calf serum (delipidated) and
200 ng/ml nerve growth factor. Myelination was induced with the
addition of ascorbate.
Oligonucleotides
Primer pairs for PCR were designed in conserved regions from
sequences available in the GenBank/EMBL database as described by Chan
et al. (1998)
. Primers were synthesized at the Genetic Engineering Facility at the University of Illinois (Urbana, IL). Oligonucleotide probes for in situ hybridization were designed according to the PCR primers and were also synthesized at the Genetic
Engineering Facility at the University of Illinois. Biotin-dT was
incorporated into each oligonucleotide probe at approximately every 15 bases. Listed below are the probes used. Bases in bold represent the
conjugated biotin label.
L19
5'-ATAGTGTCGGACATGGACTTCCAGTTTCCCTTACACAAGTTTTTG-3'
Myelin Basic Protein (MBP)
5'-CCCCTCCTTCTCTGTCGGCGAGACCTAGAGGGTACCGTTC-3'
3
-HSD
5'-CTTACCCCGGAGGCGGAACTAAGGTCGACCTCGGAA-GGAGACGGGGAC-3'
Cytochrome P450scc
5'-GGACTACGGACTCTTCGGATAGAAGAAGTTGAAGG-TCGGA-3'
Reverse Transcription PCR
RT-PCR was performed according to Chan et al. (1998)
.
Briefly, RNA from cultured cells was isolated using RNAgents Total
Isolation System (Promega, Madison, WI). The concentration and purity
of total RNA was determined by measuring the optical density at 260 and
280 nm. The RNA was subjected to DNase treatment (DNase I, FPLCpure,
Pharmacia Biotech, Piscataway, NJ) and then reverse transcription.
Residual RNA was then digested with Ribonuclease H. The cDNA was
subjected to 30 cycles of amplification using a Minicycler (MJ
Research, Watertown, MA). The amplification reactions and conditions
are described previously by Chan et al. (1998)
. Detection
and quantitation were accomplished with a phosphoimager, the ImageQuant
software (Molecular Dynamics, Sunnyvale, CA), and the IPlab Images
Software (Signal Analytics, Vienna, VA). The relative levels of gene
expression were measured by determining a ratio between the products
generated from the target gene and the endogenous internal standard in
separate reactions (Horikoshi et al., 1993
). The linear
range for amplifying regions of the genes of interest and the gene for
the internal standard were determined by serial dilutions of the cDNA.
The slopes of the lines for the intensity of the amplified cDNA versus
concentration were calculated and the ratios of the gene of interest to
the internal standard were compared. The fold increase observed is relative to premyelinating cultures at 3 days after seeding.
mRNA Differential Display PCR
RNA from cultured cells was isolated using the RNAgents Total
Isolation System. The RNA was subjected to Dnase treatment at 37°C
for 15 min to remove residual genomic DNA. Differential display was
accomplished with the RNAimage mRNA Differential Display System (GenHunter Corp., Nashville, TN). Briefly, three separate reverse transcription reactions were performed with each RNA sample, using the
one-base anchored oligo-dT primers. Reverse transcription reactions
without the reverse transcriptase were heated to 65°C for 5 min, then
to 37°C for 60 min. After 10 min at 37°C, the MMLV reverse
transcriptase was added to each reaction. After the 37°C incubation,
the samples were heated to 75°C for 5 min to inactivate the enzyme.
PCR was performed for 40 cycles using
-[33P]dATP (2000 Ci/mmol), the anchored
oligo-dT primers (HT11A,
HT11C, HT11G), the eight
different degenerate primers provided by the RNAimage kit
(HAP-1-HAP-8), and a degenerate primer synthesized by the Genetic
Engineering Facility at the University of Illinois (HAP-0). Each cycle
consisted of a denaturation step (94°C, 30 s), an annealing step
(40°C, 2 min), and an elongation step (72°C, 30 s), with a
final 5-min elongation after the last cycle. The PCR products were
electrophoresed on a 6% denaturing polyacrylamide gel and analyzed
using a phosphoimager and the ImageQuant software. Autoradiograms were
oriented on the dried gels, and the bands of interest were isolated and
purified using 3 M sodium acetate, glycogen (10 mg/ml), and EtOH at
-80°C. The products were reamplified, gel purified, subcloned using
the PCR-TRAP Cloning System (GenHunter Corp., Nashville, TN), sequenced
and purified using the ABI Prism BigDye Terminator Cycle Sequencing
Ready Reaction Kit (PE Applied Biosystems, Foster City, CA) and
Centri-sep Spin Columns (Princeton Separations, Adelphia, NJ).
In Situ Hybridization
In situ hybridization was performed using the Life
TechnologiesBRL In Situ Hybridization and Detection System
(Life TechnologiesBRL, Gaithersburg, MD). This detection system employs
the alkaline phosphatase enzyme conjugated to strepavidin. Biotinylated
oligonucleotides were designed in conserved regions from sequences
available in the GenBank/EMBL database. The 40-mer oligonucleotide
probes for cytochrome P450scc, 3
-HSD, MBP, and L19 were synthesized
at the Genetic Engineering Facility at the University of Illinois
(Urbana, IL). Biotin-dT was incorporated into each oligonucleotide
probe at approximately every 15 bases. The final probe concentration was determined by serial dilutions until an adequate signal was obtained (0.05-0.1 µg/µl). All probes were verified by Northern Blot analysis using the Life TechnologiesBRL BlueGene Nonradioactive Nucleic Acid Detection System (Life TechnologiesBRL). Dilutions were
made in a hybridization buffer composed of 4X SSC [1X SSC (pH 7.0):
0.15 M sodium chloride, 0.015 M sodium citrate], 0.2 M sodium
phosphate (pH 6.5), 2X Denhardt's solution, 10% dextran sulfate in
formamide, and 0.1 µg/ml sodium azide. Pretreatment and hybridization
were accomplished by fixing Schwann cell/neuronal cocultures with 4%
paraformaldehyde in phosphate buffer saline [8.1 mM sodium phosphate,
1.5 mM potassium phosphate (pH 7.0), 137 mM sodium chloride, and 2.7 mM
potassium chloride] at room temperature for 5 min. The slides were
washed twice with phosphate-buffered saline before dehydration with 50, 70, 90, and 100% ethanol (2 min each). Cultures were incubated with
oligonucleotide probes overnight at 45°C in a humid atmosphere. After
hybridization, the slides were washed twice with 0.2X SSC at 25°C for
15 min. Slides were then treated with a blocking solution for 15 min at 25°C and incubated with a strepavidin-alkaline phosphatase conjugate (40 µg/ml) in 100 mM Tris-HCl (pH 7.8), 150 mM magnesium chloride, 10 mg/ml bovine serum albumin, and 0.2 mg/ml sodium azide for 15 min at
25°C. The slides were washed twice with Tris buffer for 15 min and
once with an alkaline substrate buffer [0.1 M Tris-base (pH 9.5), 0.15 M sodium chloride, and 0.05 M magnesium chloride]. Cultures were
incubated in a prewarmed (37°C) solution of 0.30 mg/ml nitroblue
tetrazolium (NBT), 0.17 mg/ml 4-bromo-5-chloro-3-indolylphosphate (BCIP), dimethylformamide, and alkaline substrate buffer for 10 min to
1 h. The color development was stopped by rinsing the slides several times with deionized water. The samples were finally dehydrated through a graded ethanol series, as previously described, and visualized by light microscopy.
Immunocytochemistry
Coverslips with cultured cells were washed in phosphate-buffered
saline (pH 7.4) and fixed 4% paraformaldehyde before dehydration through a graded ethanol series (50, 70, 90, and 100%). Cultures were
blocked in SuperBlock (Pierce, Rockford, IL) for 20 min at 25°C and
then incubated with the selected primary monoclonal antibody [antiprogesterone receptor antibody (Affinity Bioreagents, Inc., Golden, CA) and an anti-S-100
-subunit antibody (Sigma, St. Louis, MO)] at 4°C overnight. The coverslips were washed in
phosphate-buffered saline and treated with a rat adsorbed biotinylated
antimouse secondary antibody (Vector Laboratories, Burlingame, CA) for
30 min at 25°C. Coverslips were washed and stained using the
horseradish peroxidase conjugated Vectastain ABC staining kit (Vector
Laboratories) and the ImmunoPure Metal Enhanced DAB Substrate (Pierce).
The horseradish peroxidase-avidin complex was applied to the cultures for 30 min at 25°C. The cultures were washed thoroughly, and the Metal Enhanced DAB substrate solution was added and incubated for ~ 5 min, or until adequate staining was achieved. Cells stained positively resulted in an intense brown/black signal.
Electron Microscopy
Electron microscopy was performed at the Center for Microscopy
and Imaging at the University of Illinois (Urbana, IL). Samples were
fixed and embedded using rapid microwave technology according to Hanker
and Giammara (1993)
and Login and Dvorak (1993)
. Briefly, samples were
fixed in a glutaraldehyde/formalin solution and chilled on ice. The
samples were then irradiated using microwave employing the use of water
load. The samples were then chilled and rinsed with Cacodylate buffer.
OsO4 was then used as a secondary fixative combined with microwave. After incubation, the samples were dehydrated using an ethanol gradient (25, 50, 75, 100%) and immersed in propylene oxide. Infiltration of the samples was accomplished by vigorous vortexing and rapid microwave. Finally, the samples were embedded in
pure epoxy and allowed to polymerize for 8-15 h at 90°C.
| |
RESULTS |
|---|
|
|
|---|
Induction of Cytochrome P450scc, 3
-HSD, and the Progesterone
Receptor
Previously, we developed a method to quantitate the biosynthetic
rate of myelin synthesis in Schwann cell/neuronal cocultures and to
determine the period of active myelin synthesis (Bilderback et
al., 1997
). Schwann cell/neuronal cocultures were established as
described in the MATERIALS AND METHODS. The cells were grown to
maturity separately, and contaminating cells were removed by cycling
with an antimitotic in the neurons and Schwann cells. After 1 wk off of
the antimitotic, neuronal cultures were seeded with the Schwann cells
(Figure 1A). Upon contact with the axons, Schwann cells proliferated rapidly. Three days after seeding, the axons
were populated with Schwann cells; however, bare axons were still
detected (Figure 1B). Seven days after seeding, the axons were fully
populated and proliferation had ceased (Figure 1C). The Schwann cells
then began to elongate and ensheath the axons. At this time the
cocultures were induced to myelinate with the addition of ascorbic acid
(50 µg/ml). Four days after induction, myelin internodes could be
detected (Figure 1D). Figure 1E illustrates a magnified view of four
adjacent Schwann cells actively forming myelin. Arrows point to the
Schwann cell bodies located in the middle of the internodes. Active
myelin synthesis occurred between 4-7 days after induction, while the
premyelinating period included the first 3 days after induction. This
allows for a distinction to be made between the premyelinating period
and the time of active myelin synthesis (Bilderback et al.,
1997
). In addition, electron microscopy was performed on the Schwann
cell/neuronal cocultures at various days after induction (Figure
2). The bulk of myelin synthesis also
occurred between 4-7 days after induction. At 3 days after induction,
Schwann cells ensheathed axons, while very few myelinated fibers were
detected (0-2 wraps of myelin). At 5 days after induction, ~ 8 wraps
of myelin were deposited by each Schwann cell. At 7 days after
induction, 10-12 wraps of myelin were observed, while after 7 days,
only a few additional wraps of myelin were deposited (maximum of 15 wraps) (Figure 2).
|
|
RT-PCR was employed to measure the relative gene expression of several
genes throughout the myelination process. Basic FGF is associated with
cell proliferation and was used as a control to aid in the
characterization of the cocultures. The mRNA for basic FGF was found to
increase by 4-fold during the proliferation phase in the cocultures
(our unpublished results). Figures 1B and C illustrate the
proliferation phase that corresponds to the induction of basic FGF. As
the Schwann cells began to differentiate and then myelinate, the
expression of the basic FGF mRNA decreased (our unpublished results).
In previous work, we showed that the mRNA for MBP increased by ~ 9-fold during active myelin synthesis (5 days after induction) and that
cytochrome P450scc, 3
-HSD, and the progesterone receptor were
induced 17-fold, 30-fold and 10-fold, respectively, during active
myelin synthesis in the cocultures (Chan et al., 1998
). When
RT-PCR was performed on Schwann cells and dorsal root ganglia neurons
cultured separately, the mRNA for cytochrome P450scc, 3
-HSD, and the
progesterone receptor were undetectable at 30 cycles of PCR (our
unpublished results). Thus, substantial expression of the mRNA for
cytochrome P450scc, 3
-HSD and the progesterone receptor occurred
only in cocultures during myelin synthesis.
In Situ Hybridization of Cytochrome P450scc and 3
-HSD
The presence of inducible enzymes responsible for steroid
biosynthesis and the dramatic effects of progestins and glucocorticoids on myelin synthesis suggest that these steroids and their metabolites may act as signaling molecules between Schwann cells and neurons. Using
biotinylated oligonucleotide probes specific for cytochrome P450scc and
3
-HSD, the localization and expression of the mRNA for the enzymes
were investigated by in situ hybridization. In primary Schwann
cell/neuronal cocultures, Schwann cells, neurons, and fibroblasts were
easily identifiable by their morphology and immunocytochemical staining
using antibodies against galactocerebroside (for Schwann cells), S-100
(for Schwann cells), and neurofilament proteins (for neurons).
Oligonucleotide probes for L19, an internal standard ribosomal protein,
and MBP were used as controls to examine the specificity of the
labeling procedure. L19 was detected in both cell types, while MBP was
exclusively localized to the myelin forming cells (our unpublished
results). The expression of cytochrome P450scc and 3
-HSD was also
examined throughout the myelination process. The mRNA for cytochrome
P450scc and 3
-HSD were undetectable in premyelinating Schwann
cell/neuronal cocultures (Figure 3A, C).
Cytochrome P450scc and 3
-HSD mRNA were only detected in the Schwann
cells of actively myelinating cocultures (Figure 3B, D). The negative
results (Figure 3A, C) were comparable to in situ hybridization
staining using sense oligonucleotide probes (our unpublished results),
and illustrate the background level of staining under these conditions.
These results demonstrate that the localization of the induced mRNA for
the enzymes is in Schwann cells and that this occurs during the period
of myelin formation. The Schwann cells that stained more intensely were
elongated and actively myelinating, as expected for a close association
between steroid biosynthesis and myelin formation.
|
Immunocytochemistry and Induction of the Progesterone Receptor
The mRNA for the progesterone receptor was not detectable by in
situ hybridization. The induced message for the progesterone receptor
during the myelinating stage was ~ 100-fold less than the
message for 3
-HSD at the premyelinating stage, which was already
below the sensitivity of the in situ hybridization technique. Consequently, a monoclonal antibody to the progesterone receptor was
employed to localize the receptor. The receptor was found in the dorsal
root ganglia neurons and localized in the cell nucleus, while minimal
staining was observed in Schwann cells (Figure
4A). The staining of Schwann cells
cultured either alone or in cocultures throughout the myelination
process was comparable to background staining observed when the primary
or secondary antibodies were omitted (our unpublished results). A
monoclonal antibody to S-100, a cytosolic Schwann cell specific
protein, was also employed as a positive control to examine the
specificity of the staining. Schwann cells were stained for S-100,
while minimal staining (comparable to background) was observed in the
neurons (Figure 4B).
|
Neurons cultured in the absence of Schwann cells and in medium lacking
steroid hormones gave a diffuse positive staining of the progesterone
receptor in the neuronal cell bodies (Figure 5A), while the addition of progesterone
(100 nM) resulted in an intense localized staining of the nuclei in the
neurons (Figure 5B). The localization of the receptor in the nucleus
suggested a nuclear translocation of the receptor in the presence of
the steroid hormone. The translocation event in the neurons was also observed in actively myelinating Schwann cell/neuronal cocultures consistent with steroid hormone production by Schwann cells. The neuronal axons were not stained and are not visible in Figure 5. It is
possible that the receptors were present in the axons, but at a level
too low to be detected. Addition of hormones to Schwann cells cultured
separately resulted in background levels of staining (our unpublished
results).
|
Besides the translocation of the receptor in neurons, the
immunocytochemical staining suggested an overall induction of the receptor in the presence of progesterone. Using RT-PCR as described previously, a dramatic auto-induction of the progesterone receptor was
observed in neuronal cultures (Figure
6A). Furthermore, to investigate the
mechanism of the progesterone receptor in myelin synthesis, the mRNA
from premyelinating and myelinating cocultures were extracted, as well
as corresponding cocultures after the addition of RU-486 (100 nM, a
progesterone receptor antagonist). Previously, the progesterone
receptor mRNA was found to be induced by 10-fold during active myelin
synthesis in cocultures (Chan et al., 1998
). Upon addition
of RU-486, the induction was completely abolished in the cocultures
(Figure 6B). RU-486 was also found to inhibit the induction of MBP in
the cocultures, consistent with its inhibition of myelin synthesis
(Koenig et al., 1995
; Chan et al., 1998
). The
addition of progesterone or RU-486 to Schwann cell cultures did not
result in detectable quantities of the progesterone receptor mRNA.
|
mRNA Differential Display
If progesterone acts on neurons via the progesterone receptor, it
should alter gene expression specifically in neurons. mRNA differential
display PCR (Liang and Pardee, 1992
; Liang et al., 1994
) was
employed to identify novel genes involved in the regulation of myelin
synthesis and the specific genes in neuronal cells that are directly
induced by the action of progesterone. The mRNA from premyelinating (3 days after induction) and myelinating (5 days after induction)
cocultures was isolated and screened for novel genes that were induced
during myelin synthesis (Figure 7). One gene, identified by differential display PCR in myelinating cocultures was 3
-HSD. This finding represents a confirmation of the previously reported induction of 3
-HSD during active myelin synthesis and illustrates that differential display technology has the potential to
identify essential genes throughout the myelination process in the
cocultures. In addition, calcineurin A (a calcium dependent phosphatase) and a rat placenta cDNA clone were also identified in
myelinating cocultures (Table 1). While
the rat cDNA clone has not yet been identified, calcineurin A was
slightly induced in myelinating cocultures. Because both 3
-HSD and
calcineurin A were unaffected by the RU-486 treatment, the induction of
these genes was not a result of the action of progesterone through the progesterone receptor. In addition, both 3
-HSD and calcineurin A
were examined in either Schwann cells cultured alone or DRG neurons
cultured alone, with and without the addition of progesterone (Table
1). While 3
-HSD was undetectable in both Schwann cells and neurons
cultured separately (30 cycles of PCR), calcineurin A was detected, but
was not modulated by progesterone. Although a total of five different
genes were isolated using differential display on myelinating
cocultures, only three out of the five genes were identified in the
GenBank/EMBL database. Only a limited number of degenerate primer sets
were used in the differential display experiments, and additional
degenerate primers should reveal more inducible genes.
|
|
To elucidate the specific genes induced by progesterone in neuronal
cells, differential display was applied to the mRNA from neuronal
cultures (no Schwann cells) with and without the addition of
progesterone (100 nM). The progesterone receptor was auto-induced by
progesterone, and differential display identified four additional genes, two of which were induced by progesterone and inhibited by
RU-486 in cocultures (Table 2). These two
genes are Rap 1b (a small Ras-like GTP-binding protein) and PRPP
(phosphoribosyl diphosphate) synthase-associated protein. The third
gene, nonmuscle myosin light chain, was not induced in the neurons with
progesterone, in cocultures during myelin synthesis, nor was it
effected by RU-486 in cocultures. Therefore, the myosin light chain
most likely represents a false positive from the differential display
PCR and is not directly related to myelin synthesis. The fourth gene was in the database (rat ovary cDNA clone #ROVAA30), but its identity is not known. A total of ten different genes were isolated using differential display on neuronal cultures with and without
progesterone, but only four of the ten genes were identified in the
GenBank/EMBL database.
|
As a control, differential display was also conducted on Schwann cell cultures with and without the addition of progesterone. In contrast to the results with the neurons, no bands were identified as being induced with progesterone, and the results suggest that progesterone has a little effect on Schwann cell transcription. Using RT-PCR, Rap 1b and PRPP synthase-associated protein were detected in Schwann cell cultures, but they were not induced by progesterone. This also means that the induction (fold-change) of the genes in the neurons observed in the cocultures (Table 2) was underestimated due to the constitutive levels of Rap 1b and PRPP synthase-associated protein in Schwann cells. In addition, progesterone added to Schwann cell cultures also did not show an induction in the mRNA for MBP, the progesterone receptor, or the myosin light chain.
| |
DISCUSSION |
|---|
|
|
|---|
Steroid hormones have dramatic and widespread effects on the
central and peripheral nervous systems. The biosynthesis and interactions of steroids in the rat brain and spinal cord independent of steroidogenic gland secretion have been well-documented (Le Goascogne et al., 1987
; Robel and Baulieu, 1994
;
Sanne and Krueger, 1995
). We have shown that endogenously synthesized
steroids in Schwann cell/neuronal cocultures affect the initiation and
regulate the biosynthetic rate of myelin synthesis (Chan et
al., 1998
). Progesterone may be synthesized in either Schwann
cells or neurons and may act as signaling molecules in the formation of
myelin. Therefore, the localization of cytochrome P450scc and 3
-HSD
expression are essential in elucidating the mechanism of steroid
hormone signaling during myelin synthesis. Using premyelinating and
myelinating cocultures, the induced expression of the mRNA for
cytochrome P450scc and 3
-HSD was localized exclusively to the
Schwann cells. Furthermore, this expression was limited to the period
of myelin synthesis.
The progesterone receptor was found in the dorsal root ganglia neurons
of cocultures during the myelination process. The dorsal root ganglia
neurons of premyelinating and myelinating cocultures were positively
stained with an antibody to the progesterone receptor with minimal
staining of the Schwann cells. The presence of the progesterone
receptor has been reported in Schwann cells by Jung-Testas et
al. (1996a)
but under different conditions than the present experiments. While in the present study the Schwann cells did not
exhibit the typical brown/black staining, these results do not exclude
the possibility that the progesterone receptor is present in lower
amounts in the Schwann cells. Our results clearly demonstrate, however,
that the induction of the enzymes responsible for progesterone
synthesis occurred in the Schwann cells, and the induction of the
progesterone receptor occurred in the DRG neurons. A prediction
stemming from these results is that progesterone should alter the
expression of genes specifically in neurons. The addition of
progesterone was found to auto-induce the progesterone receptor and to
cause the translocation of the receptor into the nuclei of the DRG
neurons cultured alone. The addition of progesterone to Schwann cells
cultured alone did not induce any nuclear staining of the progesterone
receptor, and displayed background staining. In addition, both MBP and
progesterone receptor mRNA were not induced by progesterone in Schwann
cell cultures.
Using mRNA differential display PCR, Rap 1b and PRPP
synthase-associated protein have been identified for the first time to be induced by progesterone in neurons. These genes were also induced in
cocultures during myelin synthesis and their induction was inhibited by
RU-486. The mRNA for these genes were detected in Schwann cell cultures
but were not modulated by the addition of progesterone. Recently, using
differential display, a Ras-like protein similar to Rap 1b was found to
be regulated by dexamethasone in AtT-20 cells (Kemppainen and Behrend,
1998
). The induction of these novel genes by progesterone suggests an
important function, but this remains to be determined.
Other studies have been carried out to determine the mechanism of how
progesterone enhances myelin gene expression. Progesterone causes an
approximate 2-fold stimulation of a luciferase reporter gene under the
control of the promoter regions of PMP22 and P0 in Schwann cell cultures (Desarnaud et al., 1998
). The
stimulation was not inhibited by RU-486, but rather RU-486 acted as an
agonist under the conditions of the experiments. Progesterone did not stimulate the expression of the PMP22 or P0
constructs in a human carcinoma cell line. The authors suggest that
progesterone may indirectly activate myelin gene promoters through
Schwann cell-specific transcription factors. In another study,
progesterone did not significantly stimulate PMP22 expression in
Schwann cells, but rather its derivatives, dihydroprogesterone and
tetrahydroprogesterone, induced PMP22 expression. The progesterone
derivatives were thought to be acting through the GABA receptor rather
than the classical progesterone receptor (Melcangi et al.,
1999
). Recently, it was shown that progesterone alone, as opposed to
forskolin pretreated Schwann cells used by Desarnaud et al. (1998)
, was
not sufficient to promote PMP22 expression in a MSC80
Schwann cell line (Sabéran-Djopneidi et al., 2000
). The response
of steroid hormones acting through their classical receptors is
modulated by complex interactions with coactivators and corepressors,
as well as chromatin remodeling mechanisms (for a review see Di Croce
et al., 1999
). Consequently, a response to a hormone depends
on the cell type and the cellular conditions. The present study was
directed at understanding what happens during myelin synthesis. Schwann
cells and neurons under other culture and developmental conditions may
behave differently. In Schwann cell/neuronal cocultures, RU-486
dramatically inhibits myelin synthesis (Koenig et al., 1995
;
Chan et al., 1998
). While Schwann cells were still found to
ensheath axons in the presence of RU-486, compact myelin was not
observed in electron micrographs, even after 15 days of induction. The
present results demonstrate that RU-486 acts as an antagonist by
blocking the action of progesterone on the classical progesterone
receptor and gene expression in neurons. The results do not exclude the
possibility that progesterone has some direct effect on Schwann cells,
but they suggest that the predominant effect of progesterone in
myelinating cocultures is on neurons. Neuronal signals are necessary
for Schwann cells to form myelin and progesterone is part of the cross
talk that prepares neurons for myelination. By further elucidating the
genes activated in the neurons by progesterone, additional factors that regulate neuronal-glial interactions and myelin synthesis may be identified.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Dr. Edward J. Roy for technical advice on immunocytochemistry; Dr. Eric V. Shusta and Adrian O. Rodriguez for their technical assistance and helpful discussions, and special thanks to Dr. H. Edward Conrad for novel insight and for reviewing the paper. This work was sponsored by a grant from the Multiple Sclerosis Society; Grant number: RG 2660.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
m-glaser{at}uiuc.edu.
| |
REFERENCES |
|---|
|
|
|---|
-hydroxysteroid dehydrogenase in rat brain as studied by in situ hybridization.
Mol. Cell. Neurosci.
5, 119-123[Medline].
6
4 in myelination.
J. Cell. Biol.
123, 1223-1236
-hydroxysteroid dehydrogenase in the rat brain.
J. Neurochem.
71, 2231-2238[Medline].
-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization.
J. Neurochem.
65, 528-536[Medline].This article has been cited by other articles:
![]() |
B. Cui, C. Wu, L. Chen, A. Ramirez, E. L. Bearer, W.-P. Li, W. C. Mobley, and S. Chu One at a time, live tracking of NGF axonal transport using quantum dots PNAS, August 21, 2007; 104(34): 13666 - 13671. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System Endocr. Rev., June 1, 2007; 28(4): 387 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Groyer, B. Eychenne, C. Girard, K. Rajkowski, M. Schumacher, and F. Cadepond Expression and Functional State of the Corticosteroid Receptors and 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Schwann Cells Endocrinology, September 1, 2006; 147(9): 4339 - 4350. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Frade Nuclear Translocation of the p75 Neurotrophin Receptor Cytoplasmic Domain in Response to Neurotrophin Binding J. Neurosci., February 9, 2005; 25(6): 1407 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. RODRIGUEZ-WAITKUS, A. J. LAFOLLETTE, B. K. NG, T. S. ZHU, H E. CONRAD, and M. GLASER Steroid Hormone Signaling between Schwann Cells and Neurons Regulates the Rate of Myelin Synthesis Ann. N.Y. Acad. Sci., December 1, 2003; 1007(1): 340 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ibanez, R. Guennoun, P. Liere, B. Eychenne, A. Pianos, M. El-Etr, E.-E. Baulieu, and M. Schumacher Developmental Expression of Genes Involved in Neurosteroidogenesis: 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase in the Rat Brain Endocrinology, July 1, 2003; 144(7): 2902 - 2911. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Inoue, J.-I. Akahira, T. Suzuki, A. D. Darnel, C. Kaneko, K. Takahashi, M. Hatori, R. Shirane, T. Kumabe, Y. Kurokawa, et al. Progesterone Production and Actions in the Human Central Nervous System and Neurogenic Tumors J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5325 - 5331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Chan, J. M. Cosgaya, Y. J. Wu, and E. M. Shooter Neurotrophins are key mediators of the myelination program in the peripheral nervous system PNAS, November 15, 2001; (2001) 251543398. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sakamoto, K. Ukena, and K. Tsutsui Effects of Progesterone Synthesized De Novo in the Developing Purkinje Cell on Its Dendritic Growth and Synaptogenesis J. Neurosci., August 15, 2001; 21(16): 6221 - 6232. [Abstract] [Full Text] [PDF] |
||||
|
|